跳至主要内容
临床试验/NCT05976165
NCT05976165招募中不适用

Breath Testing for Small Intestinal Bacterial Overgrowth in Patients Treated With Proton Pump Inhibitors

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2023年11月17日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
Mayo Clinic
入组人数
50
试验地点
1
主要终点
Incidence of SIBO after treatment with PPI

研究概览

简要总结

Researchers hope to determine how often small intestinal bacterial overgrowth occurs after taking proton pump inhibitors.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Predominant symptoms of gastroesophageal reflux disease including heartburn, regurgitation
  • Subjects must be able to give appropriate informed consent

排除标准

  • Prior diagnosis of SIBO
  • Use of PPIs or H2R-anatagonstists in the prior 3 months
  • Major concomitant illness (renal, hepatic, rheumatologic or cardiovascular disease, or malignancy)
  • Antibiotic therapy within one month
  • Prior gastrointestinal surgery including esophageal, gastric, and small or large bowel surgery
  • Previously diagnosed irritable bowel syndrome or inflammatory bowel disease
  • Individuals who are pregnant or breast feeding
  • Patients with plans to become pregnant
  • Inability to take PPIs, including allergy/sensitivity

研究组 & 干预措施

Breath Test Evaluation for SIBO

Experimental

Subjects with symptoms of gastroesophageal reflux disease (GERD) treated with a short course of proton pump inhibitors (PPI) clinically will undergo breath testing evaluating for small intestinal bacterial overgrowth (SIBO).

干预措施: Breath Testing (Other)

结局指标

主要结局

Incidence of SIBO after treatment with PPI

时间窗: After PPI therapy, approximately 8 weeks

Number of subjects to have a positive breath testing for small intestinal bacterial overgrowth (SIBO) after clinical treatment of proton pump inhibitors (PPI ).

次要结局

  • Symptoms of SIBO after treatment with PPI(After PPI therapy, approximately 8 weeks)
  • Symptoms of SIBO before treatment with a PPI(Baseline)
  • Incidence of SIBO before treatment with a PPI(Baseline)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Andree H. Koop

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验